Tilray Brands Inc
NASDAQ: TLRY
$1.47
+$0.07 (+5.0%)
Closing Price on November 12, 2024
TLRY Articles
Cannabis stocks have disappointed but the coronavirus lockdown might boost consumer demand.
Published:
That last year was a terrible one for marijuana stocks is indisputable. So far, 2020 has not been much kinder, with Tilray shares down by more than 50% year to date. Yet, the company said it expects...
Published:
The April 30 short interest data have been compared with the previous figures, and short interest in most of these selected marijuana stocks increased.
Published:
It’s too soon to tell what impact COVID-19 will have on legal and medical cannabis companies such as Canada’s Tilray Inc. But analysts will be watching the company’s next earnings report for...
Published:
The April 15 short interest data have been compared with the previous figures, and short interest in most of these selected marijuana stocks increased.
Published:
While markets have been recovering since mid-March, cannabis stocks as a whole have not kept pace. Tilray shares have performed the best in this time, more than doubling off of their all-time lows.
Published:
Thursday's top analyst upgrades and downgrades included Bed Bath & Beyond, Ciena, DocuSign, eHealth, Faceboook, Netflix, PNC Financial Services, Square, Tilray, Twitter and Zoom Video Communications.
Published:
The March 31 short interest data have been compared with the previous figures, and short interest in most of these selected marijuana stocks decreased.
Published:
Can Aurora Cannabis do anything to avoid the same fate as its peers that are circling the drain? Can anything the company does return it to its former glory?
Published:
It’s no secret that the cannabis industry has been smoked so far in 2020. Out of this group, Organigram seems to have fared the best. What comes next?
Published:
Canadian pot grower Tilray has released 11 million shares of common stock that had been subject to a lockup period following the company's merger with its largest holder last September.
Published:
Something is moving Tilray stock far higher than other pot stocks. What can account for a 67% one-day jump in the cannabis company's share price?
Published:
For an industry that has been crushed since it entered the market, investors have to wonder if the pain is almost over for the cannabis stocks. Aphria may hold some answers.
Published:
Last Updated:
Tilray chose perhaps the worst time that it could to raise capital, as the prior trading day was the worst one that the markets have seen since the 1987 crash.
Published:
The February 28 short interest data have been compared with the previous figures, and short interest in most of these selected marijuana stocks decreased.
Published: